Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
07/09/2026 13:38
BRIEF-Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada Sept 7 (Reuters) - Neuland Laboratories Limited NEUL.NS:
APPROVES CAPITAL EXPENDITURE OF 1.26 BILLION RUPEES FOR LAND PURCHASE IN KAKINADA
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees